Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Leonetti

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Chemical Biology & Drug Design|June 23, 2016
Design, synthesis, biological evaluation, NMR and DFT studies of structurally simplified trimethoxy benzamides as selective P-glycoprotein inhibitors: the role of molecular flatnessAngela Stefanachi, Giuseppe Felice Mangiatordi, Piero Tardia, et al.
Journal of Cheminformatics|July 7, 2026
MINERVA: a public XAI-powered platform advancing multi-target discovery in Alzheimer's diseaseNicola Gambacorta, Daniela Trisciuzzi, Fabrizio Mastrolorito, et al.
Journal of Medicinal Chemistry|November 25, 2011
Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoproteinRaffaella Zoe Pellicani, Angela Stefanachi, Mauro Niso, et al.
European Journal of Medicinal Chemistry|November 15, 2012
Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9Orazio Nicolotti, Marco Catto, Ilenia Giangreco, et al.
Bioorganic & Medicinal Chemistry|October 22, 2008
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationshipsAngela Stefanachi, Orazio Nicolotti, Francesco Leonetti, et al.
ACS Omega|July 21, 2020
Enhancing the Sensitivity of Biotinylated Surfaces by Tailoring the Design of the Mixed Self-Assembled Monolayer SynthesisDavide Blasi, Lucia Sarcina, Angelo Tricase, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Structure activity studies of a novel cytotoxic benzodiazepineAnthony Boitano, Cory D Emal, Francesco Leonetti, et al.
Cancers|March 15, 2019
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic CancerLetizia Porcelli, Rosa Maria Iacobazzi, Roberta Di Fonte, et al.
Cancers|October 13, 2021
Effect of Peptide Receptor Radionuclide Therapy in Combination with Temozolomide against Tumor Angiogenesis in a Glioblastoma ModelSang Hee Lee, Ji Young Choi, Jae Ho Jung, et al.
Journal of Medicinal Chemistry|March 23, 2011
Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivityAna Conejo-García, Leonardo Pisani, Maria del Carmen Núñez, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Chemical Biology & Drug Design|June 23, 2016
Design, synthesis, biological evaluation, NMR and DFT studies of structurally simplified trimethoxy benzamides as selective P-glycoprotein inhibitors: the role of molecular flatnessAngela Stefanachi, Giuseppe Felice Mangiatordi, Piero Tardia, et al.
Journal of Cheminformatics|July 7, 2026
MINERVA: a public XAI-powered platform advancing multi-target discovery in Alzheimer's diseaseNicola Gambacorta, Daniela Trisciuzzi, Fabrizio Mastrolorito, et al.
Journal of Medicinal Chemistry|November 25, 2011
Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoproteinRaffaella Zoe Pellicani, Angela Stefanachi, Mauro Niso, et al.
European Journal of Medicinal Chemistry|November 15, 2012
Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9Orazio Nicolotti, Marco Catto, Ilenia Giangreco, et al.
Bioorganic & Medicinal Chemistry|October 22, 2008
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationshipsAngela Stefanachi, Orazio Nicolotti, Francesco Leonetti, et al.
ACS Omega|July 21, 2020
Enhancing the Sensitivity of Biotinylated Surfaces by Tailoring the Design of the Mixed Self-Assembled Monolayer SynthesisDavide Blasi, Lucia Sarcina, Angelo Tricase, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Structure activity studies of a novel cytotoxic benzodiazepineAnthony Boitano, Cory D Emal, Francesco Leonetti, et al.
Cancers|March 15, 2019
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic CancerLetizia Porcelli, Rosa Maria Iacobazzi, Roberta Di Fonte, et al.
Cancers|October 13, 2021
Effect of Peptide Receptor Radionuclide Therapy in Combination with Temozolomide against Tumor Angiogenesis in a Glioblastoma ModelSang Hee Lee, Ji Young Choi, Jae Ho Jung, et al.
Journal of Medicinal Chemistry|March 23, 2011
Homodimeric bis-quaternary heterocyclic ammonium salts as potent acetyl- and butyrylcholinesterase inhibitors: a systematic investigation of the influence of linker and cationic heads over affinity and selectivityAna Conejo-García, Leonardo Pisani, Maria del Carmen Núñez, et al.
Pageof 8